USANA Health Sciences (NYSE:USNA) Shares Up 4.3% Following Better-Than-Expected Earnings

USANA Health Sciences, Inc. (NYSE:USNA) traded up 4.3% during trading on Wednesday following a stronger than expected earnings report. The stock traded as high as $36.10 and last traded at $35.97. 16,007 shares were traded during mid-day trading, a decline of 80% from the average session volume of 79,591 shares. The stock had previously closed at $34.48.

The company reported $0.56 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $0.49 by $0.07. The company had revenue of $200.22 million during the quarter, compared to analyst estimates of $208.45 million. USANA Health Sciences had a return on equity of 11.13% and a net margin of 6.29%. During the same quarter in the previous year, the firm posted $0.59 EPS.

Analyst Ratings Changes

USNA has been the topic of several research reports. DA Davidson dropped their price target on USANA Health Sciences from $38.00 to $35.00 and set a “neutral” rating on the stock in a report on Wednesday. StockNews.com downgraded shares of USANA Health Sciences from a “strong-buy” rating to a “buy” rating in a research note on Wednesday, July 24th.

Insider Activity at USANA Health Sciences

In related news, Director Gilbert A. Fuller sold 674 shares of USANA Health Sciences stock in a transaction on Wednesday, August 7th. The stock was sold at an average price of $39.69, for a total transaction of $26,751.06. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through this hyperlink. In other news, Director Gilbert A. Fuller sold 674 shares of the firm’s stock in a transaction on Wednesday, August 7th. The shares were sold at an average price of $39.69, for a total transaction of $26,751.06. The transaction was disclosed in a filing with the SEC, which is accessible through this link. Also, Director John Turman Fleming sold 1,000 shares of the firm’s stock in a transaction dated Wednesday, July 31st. The shares were sold at an average price of $44.43, for a total value of $44,430.00. Following the transaction, the director now owns 2,503 shares in the company, valued at approximately $111,208.29. This trade represents a 0.00 % decrease in their ownership of the stock. The disclosure for this sale can be found here. Over the last three months, insiders have sold 7,940 shares of company stock valued at $311,670. Corporate insiders own 0.33% of the company’s stock.

Institutional Trading of USANA Health Sciences

Several hedge funds have recently added to or reduced their stakes in USNA. BOKF NA grew its stake in shares of USANA Health Sciences by 274.5% in the first quarter. BOKF NA now owns 2,771 shares of the company’s stock worth $133,000 after acquiring an additional 2,031 shares during the last quarter. Price T Rowe Associates Inc. MD grew its position in USANA Health Sciences by 9.2% in the 1st quarter. Price T Rowe Associates Inc. MD now owns 5,849 shares of the company’s stock worth $284,000 after purchasing an additional 494 shares during the last quarter. DGS Capital Management LLC grew its position in USANA Health Sciences by 61.8% in the 1st quarter. DGS Capital Management LLC now owns 7,258 shares of the company’s stock worth $352,000 after purchasing an additional 2,773 shares during the last quarter. SG Americas Securities LLC acquired a new position in shares of USANA Health Sciences during the second quarter valued at about $340,000. Finally, Exchange Traded Concepts LLC raised its holdings in USANA Health Sciences by 4.4% in the 3rd quarter. Exchange Traded Concepts LLC now owns 7,709 shares of the company’s stock valued at $292,000 after acquiring an additional 322 shares in the last quarter. Institutional investors own 54.25% of the company’s stock.

USANA Health Sciences Stock Performance

The company has a market cap of $677.64 million, a price-to-earnings ratio of 10.55, a PEG ratio of 1.20 and a beta of 0.89. The business’s 50 day moving average price is $38.02 and its 200-day moving average price is $42.59.

USANA Health Sciences Company Profile

USANA Health Sciences, Inc develops, manufactures, and sells science-based nutritional, personal care, and skincare products in the Asia Pacific, the Americas, and Europe. The company offers USANA nutritional products that comprise essentials/CellSentials, such as vitamin and mineral supplements that provide a foundation of total body nutrition for various age groups; optimizers consisting of targeted supplements that are designed to meet cardiovascular, skeletal/structural, and digestive health needs; and food that include meal replacement shakes, snack bars, and other related products.